AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2010

Sep 14, 2010

34023_dirs_2010-09-14_79fc68d9-c17b-4612-b048-a192a50306c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-09-10

Reporting Person: Sharp Shalini (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-09-10	Common Stock	A	5000	$0.93	Acquired	246098	Direct
2010-09-14	Common Stock	S	2000	$0.9118	Disposed	244098	Direct

Footnotes

F1: Represents settlement of restricted stock awarded on September 10, 2008.

F2: Represents shares sold to cover minimum federal, state, and local tax withholding requirements upon the vesting of the restricted shares awarded on September 10, 2008.